Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116711982 | 11671198 | 2 | F | 20160606 | 20151028 | 20160817 | PER | US-ASTRAZENECA-2015SF01442 | ASTRAZENECA | 0.00 | M | Y | 81.60000 | KG | 20160818 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116711982 | 11671198 | 1 | PS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | 204760 | 25 | MG | TABLET | QD | |||||||
116711982 | 11671198 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | Unknown | U | 0 | 50 | MG | BID | |||||||
116711982 | 11671198 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | 10 | MG | QD | |||||||||
116711982 | 11671198 | 4 | C | K-CITRATE | 2 | 0 | 10 | MG | BID | ||||||||||
116711982 | 11671198 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 10 | MG | QD | |||||||||
116711982 | 11671198 | 6 | C | ALPRAZALOM | 2 | 0 | .5 | MG | BID | ||||||||||
116711982 | 11671198 | 7 | C | CITROBENZOPRINE | 2 | 0 | 10 | MG | Q8H | ||||||||||
116711982 | 11671198 | 8 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | 10 | MG | BID | |||||||||
116711982 | 11671198 | 9 | C | REMACAIDE | 2 | EVERY 2 MONTHS | 0 | INTRAVENOUS INFUSION | |||||||||||
116711982 | 11671198 | 10 | C | METACAPURINE | 2 | 0 | 50 | MG | QD | ||||||||||
116711982 | 11671198 | 11 | C | MOM | MAGNESIUM HYDROXIDE | 1 | 0 | ||||||||||||
116711982 | 11671198 | 12 | C | DULCOLAX NOS | BISACODYL OR DOCUSATE SODIUM | 1 | 0 | ||||||||||||
116711982 | 11671198 | 13 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
116711982 | 11671198 | 14 | C | RELESTOR | 2 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116711982 | 11671198 | 1 | Constipation |
116711982 | 11671198 | 11 | Laxative supportive care |
116711982 | 11671198 | 12 | Laxative supportive care |
116711982 | 11671198 | 13 | Laxative supportive care |
116711982 | 11671198 | 14 | Constipation |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116711982 | 11671198 | Abdominal pain upper | |
116711982 | 11671198 | Back pain | |
116711982 | 11671198 | Constipation | |
116711982 | 11671198 | Myalgia | |
116711982 | 11671198 | Neck pain | |
116711982 | 11671198 | Nephrolithiasis | |
116711982 | 11671198 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116711982 | 11671198 | 1 | 20151009 | 0 |